Letermovir Interactions
There are 409 drugs known to interact with letermovir, along with 2 disease interactions. Of the total drug interactions, 90 are major, 297 are moderate, and 22 are minor.
- View all 409 medications that may interact with letermovir
- View letermovir disease interactions (2)
Most frequently checked interactions
View interaction reports for letermovir and the medicines listed below.
- Alcohol (contained in alcoholic beverages) (ethanol)
- Allegra (fexofenadine)
- Bactrim (sulfamethoxazole / trimethoprim)
- CellCept (mycophenolate mofetil)
- Claritin (loratadine)
- Clotrimazole Troche (clotrimazole)
- CoQ10 (ubiquinone)
- Cresemba (isavuconazonium)
- Emend (aprepitant)
- FIRST Mouthwash BLM (aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Levaquin (levofloxacin)
- Lithium Carbonate ER (lithium)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Protonix (pantoprazole)
- Valproate Sodium (valproic acid)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
Letermovir disease interactions
There are 2 disease interactions with letermovir which include:
More about letermovir
- letermovir consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antivirals
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.